CATALENT MTI PHARMA SOLUTIONS LIMITED
Get an alert when CATALENT MTI PHARMA SOLUTIONS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£4.1m
Equity attributable
Employees
0
Average over period
Profit before tax
-£20k
Period ending 2025-12-31
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
the directors have assessed the going concern of the legal entity through to 31 August 2027. The company has limited activity and has limited cash flows outside of the Catalent Inc group. It is in a net current liabilities position as of 31 December 2025 and is therefore reliant on the support of Catalent to satisfy the going concern assumption.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-06-30 | 2024-06-30 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£7,540 | -£11,491 | -£19,825 | — | |
| Profit before tax | £7,409,006 | -£11,491 | -£19,825 | — | |
| Net profit | £7,409,006 | -£11,491 | -£19,825 | — | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | £4,138,623 | £4,118,798 | — | |
| Net assets | £4,150,114 | £4,138,623 | £4,118,798 | — | |
| Equity | £4,150,114 | £4,138,623 | £4,118,798 | — | |
| Average employees | — | 0 | 0 | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing covers about 18 months versus 12 months prior. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-06-30 | 2024-06-30 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | -0.3% | -0.5% | |
| Gearing (liabilities / total assets) | — | 10.1% | 10.5% | |
| Interest cover | -0.03x | — | — |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CATALENT MTI PHARMA SOLUTIONS LIMITED 2015-07-01 → present
- MTI PHARMA SOLUTIONS LTD 2012-12-20 → 2015-07-01
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“the directors have assessed the going concern of the legal entity through to 31 August 2027. The company has limited activity and has limited cash flows outside of the Catalent Inc group. It is in a net current liabilities position as of 31 December 2025 and is therefore reliant on the support of Catalent to satisfy the going concern assumption.”
Group structure
- CATALENT MTI PHARMA SOLUTIONS LIMITED · parent
- Catalent Micron Technologies Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 18 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CERON, Ramon Javier, Mr. | Director | 2025-08-29 | Aug 1969 | American |
| ELIA, Giuseppe, Mr. | Director | 2025-11-12 | Feb 1981 | British |
| HOPSON, Ricky, Mr. | Director | 2025-08-29 | Jun 1975 | American |
Show 18 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FORDE, Nyssa | Secretary | 2018-03-29 | 2024-10-22 |
| HUNEAU, Jeremy | Secretary | 2015-12-16 | 2016-05-06 |
| JOSEPH, Wetteny | Secretary | 2014-11-13 | 2015-12-16 |
| ALTMAN, Matthew Laurence | Director | 2012-12-20 | 2014-11-13 |
| ARNOLD, Jonathan | Director | 2018-03-29 | 2022-09-14 |
| CASTELLANO, Tom | Director | 2021-06-03 | 2022-09-14 |
| DROST, Joseph David, Ceo | Director | 2013-03-11 | 2014-11-13 |
| FASMAN, Steven | Director | 2014-11-13 | 2023-09-13 |
| HAWKESWOOD, Thomas | Director | 2022-09-14 | 2025-09-29 |
| HOULTON, Scott | Director | 2014-11-13 | 2015-12-14 |
| JOSEPH, Wetteny | Director | 2018-03-29 | 2021-06-03 |
| KEANE, James | Director | 2024-02-01 | 2025-11-12 |
| LARRAN, Jean Martin | Director | 2013-03-11 | 2014-11-13 |
| LITTLEJOHNS, Barry | Director | 2015-12-14 | 2018-03-29 |
| MANOS, Peter | Director | 2013-03-11 | 2014-11-13 |
| SWANSTON, Philip | Director | 2022-09-14 | 2024-01-05 |
| WALSH, Mattew, Dr | Director | 2014-11-13 | 2018-03-29 |
| WODLINGER, David, Director Board Of Directors | Director | 2013-03-11 | 2014-11-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Catalent, Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-04-23 | Active |
Filing timeline
Last 20 of 88 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-18 | AA | accounts | Accounts with accounts type full | |
| 2026-03-16 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-20 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-20 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-13 | AA | accounts | Accounts with accounts type full | |
| 2025-02-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-13 | AA01 | accounts | Change account reference date company current extended | |
| 2024-10-22 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-06-05 | AA | accounts | Accounts with accounts type full | |
| 2024-02-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-11 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-19 | AA | accounts | Accounts with accounts type full | |
| 2023-01-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-01 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-31 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.